- Home
- SPTN vs SVRA Comparison
SPTN vs SVRA Comparison
Compare SPTN & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- SVRA
- Stock Information
- Founded
- SPTN 1917
- SVRA N/A
- Country
- SPTN United States
- SVRA United States
- Employees
- SPTN 17000
- SVRA N/A
- Industry
- SPTN Food Distributors
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- SVRA Health Care
- Exchange
- SPTN Nasdaq
- SVRA Nasdaq
- Market Cap
- SPTN 630.9M
- SVRA 458.2M
- IPO Year
- SPTN N/A
- SVRA N/A
- Fundamental
- Price
- SPTN $18.69
- SVRA $2.85
- Analyst Decision
- SPTN Hold
- SVRA Buy
- Analyst Count
- SPTN 1
- SVRA 7
- Target Price
- SPTN $20.00
- SVRA $9.86
- AVG Volume (30 Days)
- SPTN 248.1K
- SVRA 1.0M
- Earning Date
- SPTN 02-12-2025
- SVRA 03-06-2025
- Dividend Yield
- SPTN 4.71%
- SVRA N/A
- EPS Growth
- SPTN 9.92
- SVRA N/A
- EPS
- SPTN 1.33
- SVRA N/A
- Revenue
- SPTN $9,532,883,000.00
- SVRA N/A
- Revenue This Year
- SPTN N/A
- SVRA N/A
- Revenue Next Year
- SPTN $2.15
- SVRA N/A
- P/E Ratio
- SPTN $14.06
- SVRA N/A
- Revenue Growth
- SPTN N/A
- SVRA N/A
- 52 Week Low
- SPTN $17.30
- SVRA $2.59
- 52 Week High
- SPTN $23.00
- SVRA $5.70
- Technical
- Relative Strength Index (RSI)
- SPTN 56.59
- SVRA 47.32
- Support Level
- SPTN $17.77
- SVRA $2.62
- Resistance Level
- SPTN $18.66
- SVRA $2.91
- Average True Range (ATR)
- SPTN 0.40
- SVRA 0.18
- MACD
- SPTN 0.11
- SVRA 0.02
- Stochastic Oscillator
- SPTN 96.19
- SVRA 47.71
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.